SCHEMBL22010820

SCHEMBL22010820

CCCCCOc1cc2oc3cc(-c4ccc(CCCC)cc4)c(F)c(F)c3c2c(F)c1F

nearest known ligand 0.40

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
RARB P10826 2/20 0.40
S1PR1 P21453 1/20 0.36
ABCB1 P08183 1/20 0.36
MPL P40238 1/20 0.35
PGAM1 P18669 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22010955 0.92 RARB (0.40) RARBS1PR1ABCB1
SCHEMBL22010835 0.91 RARB (0.40) RARBABCB1MPL
SCHEMBL22011081 0.88 MAOB (0.36) S1PR1ABCB1
SCHEMBL22010998 0.84 RARB (0.44) RARBS1PR1ABCB1MPL
SCHEMBL22010988 0.84 MPL (0.37) RARBS1PR1ABCB1MPL
SCHEMBL22011803 0.83 CALM1 (0.35) S1PR1MPL
SCHEMBL22010968 0.81 PGAM1 (0.42) S1PR1PGAM1
SCHEMBL22011181 0.81 PGAM1 (0.42) ABCB1PGAM1
SCHEMBL22011103 0.80 RARB (0.42) RARBABCB1
SCHEMBL25693861 0.79 RARB (0.45) RARBS1PR1MPL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device JNC CORPORATION (JP) 2020-05-26 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10662378-B2 Compound having fluorodibenzofuran ring, liquid crystal composition and liquid crystal display device YBX1, ZKSCAN2, RCC1 RARB 2226/4885S1PR1 1710/4885ABCB1 1178/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.